---
title: "Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (N... — FDA record D-0488-2024 | Is It on Recall"
description: "Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers."
url: https://isitonrecall.com/recall/fda-drug-d-0488-2024-timolol-maleate-ophthalmic-solution-usp-0-5-packaged-in-a-5ml-bottles-ndc-64980-514-05-and-b-15-ml-b/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (... — FDA record D-0488-2024

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 25, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ
- **Reason**: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
- **Classification**: Class II
- **Recalling firm**: FDC Limited
- **Quantity**: 382,104 units
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0488-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0488-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

New Jersey Only

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [New Jersey](https://isitonrecall.com/state/new-jersey/)

## Dates in the source

- **Report date**: May 15, 2024
- **Recall initiation date**: Apr 25, 2024
- **Center classification date**: May 7, 2024
- **Termination date**: May 21, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0488-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [FDC Limited records](https://isitonrecall.com/brand/fdc-limited/)